Oncy analyst target price
Web03. apr 2024. · Stock Price Forecast. According to 9 stock analysts, the average 12-month stock price forecast for ONCY stock is $5.51, which predicts an increase of 248.73%. The lowest target is $4.51 and the highest is $6.65. On average, analysts rate ONCY stock as … WebFind the latest Oncolytics Biotech Inc. ONCY analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. report ...
Oncy analyst target price
Did you know?
WebOncolytics Biotech News. Canaccord analyst John Newman lowered the firm’s price target on Oncolytics to $5.00 from $6.00 and keeps a... Cantor Fitzgerald analyst Louise Chen initiated coverage of Oncolytics with an Overweight rating and C$9 price target. WebONCY Stock 12 Months Forecast. $6.79. (447.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Oncolytics Biotech in the last 3 months. The average price target is $6.79 with a high forecast of $15.00 and a low forecast of $3.00. The average price target represents a 447.58% change from the last price of $1.24.
Web02. feb 2024. · ONCY 4.84%. 72. See ONCY Report. InvestorsObserver is giving Oncolytics Biotech Inc (ONCY) an Analyst Rating Rank of 52, meaning ONCY is ranked higher by analysts than 52% of stocks. The average price target for ONCY is $10.815 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating ONCY a Strong Buy today.
WebThe 3 analysts offering price forecasts for Oncolytics Biotech have a median target of 7.67, with a high estimate of 15.00 and a low estimate of 3.00. The median estimate represents a 15.39 ... WebOncolytics Biotech Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ONCY updated stock price target summary. ... Stock Price Target ONCY. High $ 15.00: Median $ 5.64 ...
WebBased on short-term price targets offered by five analysts, the average price target for Oncolytics Biotech Inc. comes to $7.25. The forecasts range from a low of $3.00 to a high of $15.00. The ...
WebFind the latest Oncolytics Biotech Inc. (ONCY) stock quote, history, news and other vital information to help you with your stock trading and investing. nih cholesterol rangeWeb07. mar 2024. · Analysts rate Oncolytics Biotech with a Strong Buy rating and a 12-month average target price of $6.00 per share. Leede Jones Gab reiterated Oncolytics Biotech with a speculative Buy Rating.. Based on the Oncolytics Biotech Inc. stock forecasts from 2 analysts, the average analyst target price for Oncolytics Biotech Inc. is USD 6.00 over … ns power easementWebPrice target. 6.93 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ONCY have a max estimate of — and a min estimate of —. ns power easement formWeb$oncy Top analyst target price for next week🎯> >--:📈📉. 14 Apr 2024 13:30:44 ns power callWeb2 days ago · Your vote is important no matter how many votes you hold. Vote today. Shareholders who have questions or need assistance with voting their shares should contact Oncolytics Biotech Inc.'s strategic advisor and proxy solicitation agent Laurel Hill Advisory Group by telephone at 1-877-452-7184 or by email at [email protected]. SAN … nih citi training courseWebThe current analyst and expert consensus on Oncolytics Biotech is Buy, with 1 strong buy opinions. The current projected Oncolytics Biotech target price consensus is 7.71 with 3 analyst opinions. The most common way Oncolytics Biotech analysts use to provide recommendation to the public is financial statements analysis. Many experts also … ns power current outage mapWebBased on 2 Wall Street analysts offering 12 month price targets for Sorrento Therapeutics in the last 3 months. The average price target is $13.00 with a high forecast of $13.00 and a low forecast of $13.00. The average price target represents a 4130.39% change from the last price of $0.31. Highest Price Target $13.00. nih chronicity index